ReviewResearch and reports in urology2018

Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens.

Yusuke Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.